Both 5-HT1B and 5-HT1F receptors modulate c-fos expression within rat trigeminal nucleus caudalis

A possible mechanism of action of antimigraine drugs such as sumatriptan is inhibition of the trigeminovascular pathway. sumatriptan's effects might b e mediated by 5-HT1B, 5-HT1D or 5-HT1F receptors. To establish the relative importance of these subtypes, we compared the effects of sumatriptan with those of a selective 5-HT1F receptor agonist (LY 344864) on c-fos protein e xpression in the trigeminal nucleus caudalis. c-fos expression was induced in urethane-anaesthetized rats by intracisternal capsaicin administration. Sumatriptan and LY 344864 decreased the number of capsaicin-induced c-fos-l ike immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 an d 0.6 mg kg(-1)). The effect of sumatriptan, but not of LY 344864, was prev ented by pretreatment with the antagonist SDZ 21-009, which displays high a ffinity for rat 5-HT1B receptors. LY 344864 appears to attenuate c-fos-like immunoreactivity via 5-HT1F receptors, while sumatriptan acts via 5-HT1B r eceptors. The fact that activation of 5-HT1F receptors is sufficient to mod ulate the activity of the trigeminal system suggests that this receptor may be a target for antimigraine drugs with improved safety profile. (C) 1999 Elsevier Science B.V. All rights reserved.